Clinical Trial of Approaches to Prostate Cancer Surgery
NCT05155501
This study is recruiting at 9 US sites in 7 states, according to its ClinicalTrials.gov record last updated .
Summary
This is a prospective, randomized controlled trial to compare cancer control and health-related quality of life following pelvic fascia-sparing radical prostatectomy versus standard radical prostatectomy. The investigators hypothesize that pelvic fascia-sparing radical prostatectomy will have similar cancer control (primary outcome) and sexual function outcomes; and significantly better urinary function, penile shortening/deformity and inguinal hernia risks as compared to radical prostatectomy.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Prostate Cancer
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 40 to 80 years
- Sex
- Male
- Healthy volunteers
- Not accepted
- Sponsor
- Weill Medical College of Cornell University
- Last updated on ClinicalTrials.gov
- April 22, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 1
- Beckman Research Institute of City of Hope · Duarte, CA
District of Columbia · 1
- Georgetown University · Washington D.C., DC
Illinois · 1
- Northwestern University · Chicago, IL
Maryland · 1
- Johns Hopkins University · Baltimore, MD
Massachusetts · 1
- Beth Israel Deaconess Medical Center (BIDMC) · Boston, MA
New Jersey · 1
- Hackensack Meridian Health · Hackensack, NJ
New York · 3
- NewYork-Presbyterian Queens · Flushing, NY
- Memorial Sloan Kettering Cancer Center · New York, NY
- Weill Cornell Medicine · New York, NY
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.